Skip to main content
. 2018 Jan 17;8:957. doi: 10.1038/s41598-017-19104-0

Figure 7.

Figure 7

DR2 antagonism inhibits T-induced stimulation of wheel running. Running-wheel activity during baseline (first three days) and after treatment with increasing doses of haloperidol (A), L-741,626 (B) and SCH23390 (C). Percentage of reduction from baseline after exposure to haloperidol (D), L-741,626 (E) and SCH23390 (F). Data in panels D–F were analyzed using two-way repeated measures ANOVA. Data are presented as mean ± SEM. In (A and D), n = 8–11 animals per group; in B and E, n = 6 animals per group; in (C and F), n = 4–6 animals per group. Statistical significance levels: *, **, ***P < 0.05, 0.01 and 0.001.